Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-comparison randomized trial of tacrolimus ointment for exfoliative cheilitis
ChiCTR1800015373Phase 4Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Nov 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in exfoliative cheilitis (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Desquamation area. Started Nov 2017; status: completed.
02
Drugs
tacrolimus
03
Conditions
exfoliative cheilitis
Beyond the preview
Go deeper on ChiCTR1800015373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015373.